Impact of Smoking on Anal Cancer Treatment Outcomes
Author Information
Author(s): Mai Sabine Kathrin, Welzel Grit, Haegele Verena, Wenz Frederik
Primary Institution: Department of Radiation Oncology of the University Medical Center Mannheim, Germany
Hypothesis
Does smoking during radiochemotherapy negatively affect the prognosis for anal cancer patients?
Conclusion
Smoking during radiochemotherapy for anal cancer may negatively influence prognosis, particularly affecting local control rates.
Supporting Evidence
- Smokers had a local control rate of 74% compared to 94% for non-smokers.
- Disease-specific survival for smokers was 82% versus 96% for non-smokers.
- The study included 68 patients with complete data for evaluation.
Takeaway
Smoking can make it harder for patients with anal cancer to get better after treatment, so doctors should talk to patients about this before starting therapy.
Methodology
The study analyzed 68 patients treated with radiochemotherapy, comparing outcomes between smokers and non-smokers.
Potential Biases
The male:female ratio was significantly different between smokers and non-smokers, which may affect the results.
Limitations
The study is retrospective and lacks detailed quantitative data on smoking habits.
Participant Demographics
34 smokers and 34 non-smokers, with a mean age of 55 for smokers and 62 for non-smokers.
Statistical Information
P-Value
0.03
Confidence Interval
not provided
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website